BARBA, T.; MARQUET, A.; BOUVRY, D.; COHEN-AUBART, F.; RUIVARD, M.; DEBARBIEUX, S.; KHOUATRA, C.; VIGHETTO, A.; DE PARISOT, A.; VALEYRE, D.; SÈVE, P. Efficacy and safety of infliximab therapy in refractory upper respiratory tract sarcoidosis: experience from the STAT registry. Sarcoidosis, Vasculitis and Diffuse Lung Disease, [S. l.], v. 34, n. 4, p. 343–351, 2018. DOI: 10.36141/svdld.v34i4.5817. Disponível em: Acesso em: 27 nov. 2021.